Michael Kreuter
Overview
Explore the profile of Michael Kreuter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
295
Citations
6967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fabbri L, Althobiani M, Tomos I, Planas-Cerezales L, Wijsenbeek M, Kreuter M, et al.
ERJ Open Res
. 2025 Mar;
11(2).
PMID: 40071274
https://bit.ly/3WAhw19.
2.
Somogyi V, Delameillieure A, Schenk S, Van Bulck L, Breuls S, Uckuyu N, et al.
Respir Res
. 2025 Feb;
26(1):81.
PMID: 40022111
Background: Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are interstitial lung diseases (ILD) that carry a high burden and mortality. IPF/PPF experts and patients call for standardized care,...
3.
Tometten M, Beier F, Kirschner M, Schumacher Y, Walter J, Vieri M, et al.
Blood Adv
. 2025 Feb;
PMID: 39938003
Pathogenic germline variants affecting proper telomere maintenance result in premature telomere shortening and cause telomere biology disorders (TBDs). While classical dyskeratosis congenita in children is rather well defined, late-onset ("cryptic")...
4.
Moen E, Prior T, Kreuter M, Wuyts W, Molina-Molina M, Wijsenbeek M, et al.
BMC Pulm Med
. 2025 Feb;
25(1):59.
PMID: 39901224
Background: Advances in the field of genetics of interstitial lung diseases (ILDs) have led to the recent consensus statements made by expert groups. International standards for genetic testing in ILD...
5.
Koschel D, Behr J, Berger M, Bonella F, Hamer O, Joest M, et al.
Respiration
. 2025 Jan;
1-82.
PMID: 39870058
German recommendations for the diagnosis of hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis (EAA), were last published in 2007 [1]. The current S2k Guideline for the Diagnosis and...
6.
Guiot J, Henket M, Gester F, Andre B, Ernst B, Frix A, et al.
Respir Res
. 2025 Jan;
26(1):39.
PMID: 39856708
Background: Systemic sclerosis (SSc) is a rare connective tissue disease associated with rapidly evolving interstitial lung disease (ILD), driving its mortality. Specific imaging-based biomarkers associated with the evolution of lung...
7.
Delameillieure A, Somogyi V, Schenk S, Toreyin N, Stenzel N, Van Bulck L, et al.
Eur Respir Rev
. 2025 Jan;
34(175.
PMID: 39843158
Introduction: People with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF) have a high symptom burden and a poor health-related quality of life (HRQoL). Despite efforts...
8.
Rosendahl S, Trudzinski F, Polke M, Herth F, Kreuter M, Giese T
Respiration
. 2024 Dec;
:1-11.
PMID: 39701048
Introduction: During the COVID-19 pandemic, the effectiveness of vaccines against SARS-CoV-2 in immunodeficient patients not only did affect the individual risk of these vulnerable patients but endangered the selection of...
9.
Kreuter M, Belloli E, Bendstrup E, Cerri S, Flaherty K, Shapera S, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39624387
Background: Acute exacerbations of fibrosing interstitial lung diseases (ILDs) are associated with high mortality. We used prospective data from the INBUILD trial to investigate risk factors for acute exacerbations and...
10.
Lancaster L, Cottin V, Ramaswamy M, Wuyts W, Gisli Jenkins R, Scholand M, et al.
Ther Adv Respir Dis
. 2024 Nov;
18:17534666241287307.
PMID: 39512136
This plain language summary shares results from a clinical study called INTEGRIS-IPF that was published in the in 2024. This study looked at a medicine called (beck-so-teh-grast) as a possible...